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Blindness and visual impairments are heavy loads for modern society. Visual prosthesis is a promising therapy 
to treat these diseases. However, electric stimulation (ES)-induced damage of the optic nerve and adjacent 
cells are problems that must not be overlooked. In the current study, we aimed to investigate the effects of ES 
on cultured microglia cells and the potential protective mechanisms from a natural compound Lycium bar-
barum polysaccharide (LBP). Cellular injuries were induced by 9 mA bipolar pulse current in BV-2 cells for 
15 min. Treatment with LBP alone or in association with either autophagic inhibitor 3-MA or autophagic ago-
nist rapamycin was preadded for 2 h before the ES challenge. After that, morphological and molecular changes 
of the cells were measured at 2 h or 6 h postchallenges. We found that ES induced evident morphological and 
pathological changes of BV-2 cells, including oxidative stress, inflammation, and apoptosis. Pretreatment with 
LBP significantly attenuated these injuries with enhanced endogenous autophagy. When cellular autophagy 
was inhibited or enhanced by corresponding drug, the protective properties of LBP were partly inhibited or 
maintained, respectively. In addition, we demonstrated that ERK and p38 MAPK exerted diversified roles in 
the protection of LBP against ES-induced cellular damages. In conclusion, LBP improves bipolar pulse current-
induced microglia cell injury through modulating autophagy and MAPK pathway. 
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life (21). Although microelectronics have been used to 
treat blindness, several problems during the application, 
particularly its safety issue and underlying mechanisms, 
remain to be fully addressed. 
For an effective and safe treatment, microelectronic 
devices should be implanted in the body for decades with 
adequate power supply and no potential corrosion and 
infection (24). However, it has been reported that acti-
vated electrodes may induce a redox reaction and electro-
lytic corrosive effects. Importantly, when microelectronic 
arrays were implanted on the optic nerve 1.0 mm behind 
the eyeball, the effects of the electric current on the adja-
cent neurons and glia cells are still uncertain. Moreover, it 
has been found that there was a glia cell layer between the 
implanted device and the retinal neurons, acting as an insu-
lating layer in the retinal implant (16). This cell layer may 
decrease the efficacy of electrical signals, and therefore a 
INTRODUCTION
Blindness is a severe public health problem with a 
heavy social burden in health and economics. According 
to the World Health Organization, the number of people 
of all ages visually impaired is estimated to be 285 mil-
lion globally, of whom 39 million are blind (26). Up to 
2010, the main causes of blindness have included cataract 
(51%), glaucoma (8%), age-related macular degeneration 
(5%), childhood blindness and corneal opacities (4%), 
uncorrected refractive errors and trachoma (3%), dia-
betic retinopathy (1%), and undetermined causes (21%) 
(25). With the appearance of the first neural prosthesis 
in the 1970s, this field has grown to a $4.7 billion indus-
try with an annual growth rate of 20% (3). Among the 
most exciting developments is visual prosthesis, which 
was designed to provide artificial visuality for the blind, 
resulting in increased independent living and quality of 
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larger current is needed to achieve the expected therapeu-
tic outcomes, which probably leads to a serious oxidation 
reaction and electrocorrosion. In the retina, microglia is 
the resident immune effector cell, which has been impli-
cated as a contributor to these neurotoxic products once 
completely activated (1,15). Thus, elucidating the effects 
of the electric current on microglial fates is vital for the 
future development and application of visual prostheses.
Autophagy is an intracellular catabolic pathway, which 
degrades cell components, toxic aggregates, and damaged 
organelles to recycle them as basic building blocks for the 
maintenance of cellular homeostasis (33). During autophagy, 
intact organelles (such as mitochondria) and portions of the 
cytosol are sequestered into a double- membrane vesicle 
to form an autophagosome, which matures later and fuses 
with an endosome and/or lysosome to form an autolyso-
some (18). Then the cargo is broken down, and the mac-
romolecules are transported back into the cytosol for reuse 
(18). Autophagy represents a cytoprotective response in 
many cell types, and its deregulation is implicated in many 
diseases, such as infectious diseases, cancer, and neurode-
generation (2,11). In the neuronal system, it protects the 
retinal ganglion cells (RGCs) from optic nerve axotomy 
(19), and its overexpression or insufficiency may induce 
neuronal death and neurological disorders (7,13).
Lycium barbarum (Wolfberry) is a traditional Chinese 
medicine used for centuries in the Eastern world to main-
tain eye health and nourish the liver and kidneys and to 
balance “Yin” and “Yang” in the body (4). Our previous 
studies found that the polysaccharide part of Wolfberry 
(LBP) could reduce neuronal damage, blood–retinal barrier 
disruption, and oxidative stress in retinal ischemia/reperfu-
sion injury (14) and antagonize glutamate excitotoxicity in 
rat cortical neurons (8). However, whether it is effective in 
reducing electric damage (e.g., oxidative stress and apopto-
sis) of the microglial cell is unknown. In the current study, 
we aimed to examine the cellular and molecular events after 
bipolar pulse current (or electric stimulation, ES) treatment 
in microglial cells in vitro. The role of autophagy during the 
damaging and recovery processes will be studied in detail. 
MATERIALS AND METHODS
Chemicals and Reagents
The preparation for LBP extracts (from Lycium bar-
barum, Ning Xia Huizu Autonomous Region, People’s 
Republic of China) was the same as reported previ-
ously (8). All cell culture consumables and reagents 
were bought from either Corning (Corning, NY, USA) 
or Gibco (Carlsbad, CA, USA). Antibodies against cata-
lase (CAT) and ED1 (cluster of differentiation 68; CD68) 
were bought from Abcam (Cambridge, UK). Beclin-1, 
autophagy protein 5 (Atg5), nucleoporin p62 (p62), light 
chain 3B (LC3B), inducible nitric oxide synthase (iNOS), 
total p38 mitogen-activated protein kinase (MAPK), 
phosphorylated p38 MAPK at Thr180/Tyr182, total extra-
cellular signal-regulated kinase (ERK), and phosphory-
lated ERK at Tyr204 antibodies were bought from Cell 
Signaling (Danvers, MA, USA). Autophagic inhibitor 
3-methyladenine (3-MA) and agonist rapamycin were 
purchased from Sigma-Aldrich (St. Louis, MO, USA).
Cell Culture and ES
Mouse normal brain microglia BV-2 cell line was 
supplied by the Cell Bank of Type Culture Collection 
of Chinese Academy of Sciences (Shanghai, China). 
BV-2 cells were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) with 10% (v/v) fetal bovine serum 
(FBS) at 37°C with 5% CO2 supply using a cell incuba-
tor (Thermo Fisher, Waltham, MA, USA). Before every 
treatment, the cells reached a confluence of 60–70%. For 
the pretreatment with 50 mg/ml LBP, 1× phosphate buff-
ered saline (PBS) dissolved LBP was added 2 h before 
the ES challenge. For 3-MA or rapamycin treatment, 10 
mM 3-MA (in PBS) or 100 nM rapamycin [in dimethyl 
sulfoxide (DMSO)] was added to the culture medium 2 h 
before the ES (with or without LBP cotreatment). 
ES of BV-2 cells was performed as previously reported 
with minor modifications (6). Briefly, ES was applied 
across a 3.5-mm dish in which two platinum-iridium 
alloy electrodes set on opposite sides of the dish are in 
contact with the medium. The ends of the electrodes were 
connected with the electric stimulator. The bipolar pulse 
current needed a stimulus isolator to magnify and was 
checked by oscilloscope in a real-time manner. Each 
stimulation pulse (15 min, 9 mA) was sufficient to induce 
potential damage in BV-2 cells, according to our pilot 
study (data not shown). The entire ES was performed in 
a biosafety cabinet where the sham groups also received 
sham treatment for 15 min, then all cells were incubated 
a 37°C, 5% CO2 incubator for 2 or 6 h. The following 
stimulation paradigms were used. Each episode consisted 
of 300 biphasic pulses at 1 Hz (0.5 ms phase duration of 
each single phase and 0.5 ms interval-phase delay). The 
ES challenge was generated by a Master-8 pulse stimula-
tor (AMPI, Jerusalem, Israel), a stimulus isolator A365 
(World Precision Instruments, Sarasota, FL, USA), and 
a TDS 1001B oscilloscope (Tektronix, Beaverton, OR, 
USA). Two and 6 h after the stimulation, cells were sub-
jected to various cellular and molecular studies. Pattern 
of ES and experiment design are shown in Figure 1.
Quantification of Apoptotic Cells
Two and 6 h after the stimulation, Hoechst 33342 
(5 μg/ml) and propidium iodide (5 μg/ml) were added to 
each dish to stain live and dead cells. The cell popula-
tion was separated into three groups: live cells showed 
only a low level of fluorescence; apoptotic cells showed a 
higher level of blue fluorescence, and dead cells showed 
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low-blue and high-red fluorescence. Stained cells were 
observed and quantified by two independent cell biolo-
gists without knowing the grouping. The results were 
expressed as the percentage of apoptosis (PA): PA = apop-
totic cell number/total cell number × 100% (30).
Caspase 3/7 Activity Measurements
Activities of caspases 3/7 from cell lysates (collected by 
RIPA buffer; Sigma-Aldrich) were measured using Caspase-
Glo 3/7 Assay Systems (Promega, Madison, WI, USA) 
according to the user’s manual. The luminescence was read 
in a Glomax luminometer (Promega) and expressed as fold 
change in caspase 3/7 activity from the control.
Live Cell Imaging and LC3 Fluorescence 
Time lapse live cell image after ES was performed on an 
Axio Observer Z1 live cell station (Carl Zeiss, Oberkochen, 
Germany). The dynamic changes of expression and local-
ization of live cell LC3 protein was visualized by transfect-
ing mouse LC3-green fluorescent protein (GFP) plasmid 
(a kind gift from Dr. Rongrong He, Pharmacy College, 
Jinan University, China) using lipofectamine 3000 (Life 
Technologies, Shanghai, China) for 24 h. 
Western Blot
Western blot analyses of cell lysates were performed as 
described previously (28). Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH; Cell Signaling) was used as the 
internal control for all experiments. 
Statistical Analysis
Data from each group were expressed as means ± SEM 
(n = 4 for each group). The statistical significance of dif-
ferences between groups was tested using one-way analy-
sis of variance (ANOVA with Bonferroni correction of 
the Student’s t-test as a post hoc test) or Student’s t-test if 
only two groups were being compared. A value of p < 0.05 
was considered to be statistically significant (Prism 5.0; 
Graphpad Software, Inc., San Diego, CA, USA).
RESULTS
Pretreatment With LBP Ameliorated ES-Induced BV-2 
Cellular Necrosis and Apoptosis After ES
Two hours after the ES challenge (9 mA for 15 min), the 
BV-2 cells shrank, which was aggravated at 6 h after the 
challenge (Fig. 2A, B). Accordingly, the number of necrotic 
and apoptotic cells was significantly increased (p < 0.001) 
(Fig. 2). When the cells were pretreated with LBP, both the 
morphology and necrotic/apoptotic status of the cells after 
ES was significantly ameliorated to control-comparable 
levels without affecting the healthy cells (p < 0.05) (Fig. 2).
Pretreatment With LBP Stabilizes the Expression and 
Cellular Localization of LC3B After ES
To examine the effects of ES and LBP pretreatment 
on cellular autophagy, the dynamic cellular localization 
and expression level of key autophagic protein LC3B 
was visualized by a time-lapse fluorescence microscopy 
Figure 1. Pattern of ES on microglia BV-2 cells. (A) Two platinum-iridium alloy electrodes set at opposite sides of the dish are in 
contact with the medium. ES was given at 9 mA for 15 min, by first negative and then later positive bipolar square pulses. The arrow 
is representative of the pulse. (B) Flow chart of ES. LBP work concentration is 50 μg/ml, pretreated before ES for 2 h. Two or 6 h later, 
cells were collected for the following measurements. 3-MA, 3-methyladenine.
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Figure 2. Ameliorative effects of LBP on the electric stimulation-induced apoptosis and necrosis of BV-2 cells. (A) Differential inter-
ference contrast (DIC) photos (200× magnification) show the representative morphology of normal BV2 microglia of control group, 
ES 9 mA-15 min-2 h group, vehicle-LBP group, and ES + LBP group after ES 2 h or 6 h. LBP was pretreated before ES 2 h at 50 μg/ml. 
(B) Fluorescent photos (100× magnification) show the propidium iodide (PI) and Hoechst double-labeled cells of the four groups. 
Orange arrows indicate the apoptosis or necrosis cells (scale bar: DIC 50 μm, fluorescence 100 μm). (C) and (D) Quantified percent-
ages of (A) and (B), respectively (n = 4 for each group). After ES, the number of apoptosis and necrosis cells increased while LBP 
significantly decreased the damage. ***Significant change (p < 0.001) between control and ES groups. # and ###Significant changes 
(p < 0.05 and p < 0.001) between ES group and ES + LBP groups.
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Figure 3. LBP stabilizes the expression and cellular localization of LC3B in BV-2 microglia cells. Representative 6-h time-lapse fluo-
rescence pictures showing the expression and localization of light chain 3B (LC3B) after transfecting with mouse LC3B-GFP plasmid 
for 24 h before the electric stimulation (A) without LBP pretreatment or (B) with LBP pretreatment. Arrows indicate the localization 
of LC3B fluorescent signals. Magnification: 400×.
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using LC3B-GFP plasmid. It was shown that before ES, 
when there was no LBP pretreatment, the level of LC3B 
in BV-2 cell was low and the cellular localization was 
spread. Two-hour pretreatment with LBP concentrated 
the LC3B expression and localization (Fig. 3). As time 
went on, the level of LC3B was slightly increased in 
the ES-only group but showed no obvious change in 
the ES + LBP group at 2 h postchallenge. At 6 h post-ES 
challenge, the level of LC3B was evidently inhibited, 
while the pretreatment with LBP still maintained the 
LC3B level and localization at a 0-min comparable level 
(Fig. 3 and supplementary videos 1 and 2 at https://
drive.google.com/file/d/0B75g-qH9l7QlbkFvcUd-
BOVlJZTQ/view?usp=sharing and https://drive.google.
com/file/d/0B75g-qH9l7QlTGFCQWJRMENVRDA/
view?usp=sharing). 
Antiapoptotic and Antioxidant Effects of LBP  
on ES-Induced BV-2 Cell Damage  
Were Mediated by Autophagy
To correlate the autophagic regulating function and 
ameliorative effects of LBP on ES-induced cellular dam-
ages, we applied the autophagic inhibitor 3-MA and 
agonist rapamycin in the study. Results of caspase 3/7 
activity showed that ES significantly increased the activ-
ity of caspase 3/7 in BV-2 cells, both at 2 h and 6 h post-
challenge (Fig. 4A). Pretreatment with LBP significantly 
reduced the caspase 3/7 activity, when compared with the 
ES group. When 3-MA was applied, it partly abolished 
the beneficial effects of LBP pretreatment on the reduc-
tion of caspase 3/7 activity (Fig. 4A). When endogenous 
autophagy was enhanced by rapamycin, an inhibitor of 
the autophagic suppressor mammalian target of rapamy-
cin (mTOR), the apoptotic-ameliorative effects of LBP 
was partly impaired at 2 h postchallenge but was further 
enhanced at 6 h post-ES challenge (Fig. 4B). 
Since oxidative stress is the direct consequence of ES 
challenge in the neuronal system, we then looked at the 
influence of both ES and LBP pretreatment on the key 
oxidative stress markers, CAT and iNOS. For CAT, ES 
did not affect its basal expression at 2 h postchallenge 
but significantly inhibited this antioxidant at 6 h post-
challenge, implying an increased oxidative stress status 
in BV-2 cells (Fig. 4C, D). This phenomenon was partly 
abolished by the addition of LBP, autophagic inhibitor 
FACING PAGE
Figure 4. LBP attenuates ES-induced apoptosis and oxidative stress through regulating autophagy. (A, B) Change of caspase 3/7 
activity in BV-2 cell groups with ES, LBP, autophagic inhibitor 3-MA, or autophagic agonist rapamycin (n = 4 for each group). 
(C) Representative Western blot pictures for the protein expression change of CAT, iNOS, and ED1 (cluster of differentiation 68; 
CD68) in BV-2 cell groups with ES, LBP, 3-MA, or rapamycin. Cells were collected 2 h after the ES challenge. (D) Western blot pic-
tures of CAT, iNOS, and ED1 of cells collected 6 h after the ES challenge. (E) Western blot pictures of Atg5, p62, beclin-1, and LC3B 
of cells collected 2 h after the ES challenge. (F) Western blot pictures of Atg5, p62, beclin-1, and LC3B of cells collected 6 h after 
the ES challenge. *, **, ***Significant changes between indicated groups (p < 0.05, p < 0.01, p < 0.001), respectively. ES/E, electric 
stimulation; L, LBP; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
3-MA, or agonist rapamycin. For iNOS, a key linker of 
oxidative stress and inflammation, its level was signifi-
cantly enhanced at both time points post-ES but ame-
liorated by LBP. Rapamycin further strengthened this 
beneficial effect of LBP (Fig. 4C, D). It should be noted 
that ED1 was activated by ES at 6 h postchallenge, which 
means an activated status of the microglia by the electric 
field. This was attenuated by LBP or rapamycin addition 
(Fig. 4C, D).
For the protein level change of key members of the 
autophagy pathway, such as Atg5, beclin-1, and LC3B, 
their level changes were consistent with the LC3B fluo-
rescence alteration during the experiment (Figs. 3 and 4E, 
F). When they were inhibited by 3-MA, their levels could 
also be recovered by the pretreatment with LBP, indicat-
ing a potent autophagic inductive ability of this natural 
compound (Fig. 4E, F). Rapamycin treatment enhanced 
all of these markers in all groups. The changes of p62 
protein expression, a substrate of the autophagic pathway, 
were inverted with the changes of other autophagic mark-
ers (Fig. 4E, F). 
MAPK Pathway Was Involved in the  
Protective Actions From LBP
The MAPK pathway is considered to be both regu-
lator and downstream target of the autophagic pathway. 
To examine its involvement in ES-induced microglia 
damage and LBP-mediated protection of BV-2 cells, 
we measured the changes of MAPK pathway members 
ERK and p38 MAPK in each group after 2 or 6 h of ES. 
In the 2-h groups, both ES and LBP pretreatment did 
not significantly change ERK and p38 MAPK levels. 
However, after 6 h, the phosphorylated level of ERK was 
inhibited while the level of phosphorylated p38 MAPK 
was induced, consistent with the concept that ERK and 
p38 MAPK are beneficial for cell survival and damage, 
respectively (Fig. 5). When autophagy was inhibited 
by 3-MA, the phosphorylation level of ERK was inhib-
ited at 2 h but not 6 h post-ES challenge, indicating that 
ERK was involved in the acute phase of ES-induced 
autophagic regulation (Fig. 5). This result was confirmed 
by the rapamycin-treated group that the basal phospho-
rylation of ERK was enhanced at 2 h post-ES challenge 
(Fig. 5A). At 6 h post-ES, both phosphorylation of ERK 
and p38 MAPK was enhanced by LBP or rapamycin, 
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suggesting that induced autophagy could upregulate the 
entire MAPK pathway in the middle to late phase of ES 
challenge (Fig. 5B). Total levels of both ERK and p38 
MAPK were not affected by ES and/or LBP in all groups. 
Collectively, our data showed that MAPK exerted diver-
sified functions on ES-induced microglial injury and 
LBP-mediated autophagic alteration. 
DISCUSSION
Visual prosthesis is one of the most exciting achieve-
ments for blindness and visual impairment therapy in the 
past 40 years. Although a number of successful applica-
tion cases have been reported in recent years, including 
increased visual acuity and safety after therapy (9,10), it is 
still difficult to avoid possible redox and physical damage 
at and near the implanting sites (5). In addition, smaller 
electrodes often mean higher charge density, which may 
cause severer tissue damages. Thus, delineating the effect 
and mechanism for ES-induced visual injury is crucial for 
the further development of this technique.
Autophagy can be rapidly activated in response to 
stress and damage in order to maintain tissue homeosta-
sis. Appropriate autophagic response is beneficial for the 
survival of cells and self-renewal of the body. However, 
when it is insufficient or hyperactivated, neurodegenera-
tion may occur due to a complicated signaling network 
(32). Previous studies have proven that autophagy was 
important for the increased survival ratio and attenuated 
degeneration of RGC postdamage (12,23), indicating that 
autophage is a double-edged sword in the neuronal sys-
tem (22). In the current study, we demonstrated that in the 
acute response phase (2 h) after ES, cellular autophagy was 
elevated to initiate endogenous protective mechanisms. 
However, when the treatment duration was prolonged 
(6 h), endogenous autophagy level was inhibited due to 
the electric-induced damage. Those damages included 
inflammatory, oxidative, and apoptotic responses, as well 
as the activation of the MAPK pathways. These results 
were consistent with a very recent study indicating that 
graphene quantum dots (GODs) could induce inflam-
mation, oxidative stress, and apoptosis in macrophage 
through regulating autophagy and p38 MAPK/nuclear fac-
tor k-light-chain-enhancer of activated B-cells (NF-kB) 
pathways (17). Another study also found that autophagic 
responses were induced in damaged murine optic nerve, 
which was closely associated with the protection of RGCs. 
However, when Atg5 was knocked out, the survival ratio 
of RGCs was significantly reduced (20). Collectively, our 
Figure 5. MAPK pathway is involved in LBP regulated autophagy after ES in BV-2 cells. (A) Representative Western blot pictures 
of phosphorylated ERK, total ERK, phosphorylated p38 MAPK, and total p38 MAPK in BV-2 cell groups with ES, LBP, 3-MA, or 
rapamycin. Cells were collected 2 h after the ES challenge. (B) Representative Western blot pictures of phosphorylated ERK, total ERK, 
phosphorylated p38 MAPK, and total p38 MAPK of cells collected 6 h after the ES challenge. ES/E, electric stimulation; L, LBP.
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investigations confirmed the beneficial roles of autophagy 
in ES-induced microglial injury.
The protective and therapeutic effects of LBP on both 
neuronal system and the liver have been demonstrated by us 
in several kinds of diseases (8,14,27,31). Besides its potent 
ability in immunological regulation, LBP can also act as 
antioxidant and autophagic regulator. For example, in non-
alcoholic fatty liver disease, consumption of LBP signifi-
cantly restored the autophagic level inhibited by metabolic 
disorders, which was strongly related to the attenuated 
hepatic damages (29). In this study, in the acute phase, pre-
treatment with LBP further enhanced the autophagic level 
elevated by the electric stimulation of BV-2 cells. After 6 h 
of the treatment, LBP significantly restored the autophagy 
inhibited by the ES. Interestingly, when autophagy was 
inhibited or further activated by 3-MA or rapamycin, the 
beneficial effects of LBP on BV-2 cells were abolished 
or stabilized, respectively. These data confirmed the key 
role of autophagy in LBP-mediated BV-2 cell protections 
against damaging high electric field. 
In conclusion, our study found that [1] high level of 
electric stimulation was injurious to microglia cells, which 
may induce inflammation, oxidative stress, and apoptosis 
events; and [2] treatment with LBP was able to protect 
microglia cells from electric stimulation-induced damages 
through modulating autophagy and MAPK pathways. 
This study may shed light on future clinical application of 
visual prosthesis and selection of food supplements for the 
therapy of blindness or other visual impairments.
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